Archive · 14 Aug 2025
Indian Scientists Explore miRNA for Alzheimer's Cure
Scientists are studying tiny molecules called microRNAs (miRNAs) to find a cure for Alzheimer's disease.
These miRNAs, which were the subject of a Nobel Prize, are being examined because they may be important in controlling Alzheimer's.
Researchers found that a specific miRNA, called miR-7a, is increased in people with Alzheimer's, and it targets a protein called Klf4.
When miR-7a targets Klf4 it causes problems that lead to Alzheimer's.
The scientists are now creating medicines that target Klf4 to try and stop these problems.
If these treatments work, they could help people with Alzheimer's and their families.
Indian scientists are exploring microRNAs (miRNAs) as a potential treatment for Alzheimer's Disease.
miRNAs, which were the subject of a Nobel Prize, may play a key role in Alzheimer's treatment and cure.
Researchers from JNCASR identified altered miRNAs in the Alzheimer's brain, which could lead to new drug development.
The study found miR-7a, which targets Klf4, a master regulator, is significantly increased in Alzheimer's patients.
Scientists are developing miRNA-based therapies that target Klf4 to prevent neuroinflammation and ferroptosis.
- Who
- Researchers from JNCASR are leading the study, including Madhu Ramesh and Prof. Thimmaiah Govindaraju.
- What
- Researchers are exploring microRNAs (miRNAs) as a potential treatment and cure for Alzheimer's Disease.
- When
- The research is ongoing, with clinical evaluation planned for the developed miRNA mimic.
- Where
- Research is being conducted at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in India.
- Why
- To find new treatments and potential cures for Alzheimer's Disease by targeting altered miRNAs in the brain.
- Disease
- Alzheimer's Disease
- Research Institute
- JNCASR
- Key Finding
- Increased miR-7a levels
- Target
- Klf4
- Treatment Approach
- miRNA-based therapies
- Therapeutic target
- Klf4